Radial porous SiO2 nanoflowers potentiate the effect of antigen/adjuvant in antitumor immunotherapy

Chuangnian Zhang, Ying Dong, Jing Gao, Xiaoli Wang, Yanjun Jiang

PDF(5369 KB)
PDF(5369 KB)
Front. Chem. Sci. Eng. ›› 2021, Vol. 15 ›› Issue (5) : 1296-1311. DOI: 10.1007/s11705-020-2034-6
RESEARCH ARTICLE

Radial porous SiO2 nanoflowers potentiate the effect of antigen/adjuvant in antitumor immunotherapy

Author information +
History +

Abstract

Here, we reported a cancer nanovaccine based on SiO2 nanoflowers with a special radial pore structure, which greatly enhanced cross-presentation and induced the production of cytotoxic T lymphocyte cells secreting granzymes B and interferon-γ. The antigen ovalbumin was covalently conjugated onto the as-synthesized hierarchical SiO2 nanoflowers, and the adjuvant cytosine-phosphate-guanine was electrostatically adsorbed into their radial pore by simple mixing before use. The nanovaccine exhibited excellent storage stability without antigen release after 27 days of incubation, negligible cytotoxicity to dendritic cells, and a high antigen loading capacity of 430 ± 66 mg·g−1 support. Besides, the nanovaccine could be internalized by dendritic cells via multiple pathways. And the enhancement of antigen/adjuvant uptake and lysosome escape of antigen were observed. Noteworthy, in vitro culture of bone marrow-derived dendritic cells in the presence of nanovaccine proved the activation of dendritic cells and antigen cross-presentation as well as secretion of proinflammatory cytokines. Besides, in vivo study verified the targeting of nanovaccine to draining lymph nodes, the complete suppression of tumor in six out of ten mice, and the triggering of notable tumor growth delay. Overall, the present results indicated that the nanovaccine can be served as a potential therapeutic vaccine to treat cancer.

Graphical abstract

Keywords

silica nanoflower / antigen delivery / cancer immunotherapy / nanovaccine

Cite this article

Download citation ▾
Chuangnian Zhang, Ying Dong, Jing Gao, Xiaoli Wang, Yanjun Jiang. Radial porous SiO2 nanoflowers potentiate the effect of antigen/adjuvant in antitumor immunotherapy. Front. Chem. Sci. Eng., 2021, 15(5): 1296‒1311 https://doi.org/10.1007/s11705-020-2034-6

References

[1]
Kelly P N. The cancer immunotherapy revolution. Science, 2018, 359(6382): 1344–1345
CrossRef Google scholar
[2]
Sahin U, Türeci Ö. Personalized vaccines for cancer immunotherapy. Science, 2018, 359(6382): 1355–1360
CrossRef Google scholar
[3]
Nam J, Son S, Park K S, Zou W, Shea L D, Moon J J. Cancer nanomedicine for combination cancer immunotherapy. Nature Reviews. Materials, 2019, 4(6): 398–414
CrossRef Google scholar
[4]
Hollingsworth R E, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines, 2019, 4(1): 7
CrossRef Google scholar
[5]
Wculek S K, Cueto F J, Mujal A M, Melero I, Krummel M F, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nature Reviews. Immunology, 2020, 20(1): 1–18
CrossRef Google scholar
[6]
Hu Z, Ott P A, Wu C J. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nature Reviews. Immunology, 2017, 18(3): 168–182
CrossRef Google scholar
[7]
Riley R S, June C H, Langer R, Mitchell M J. Delivery technologies for cancer immunotherapy. Nature Reviews. Drug Discovery, 2019, 18(3): 175–196
CrossRef Google scholar
[8]
Huang P, Wang X, Liang X, Yang J, Zhang C, Kong D, Wang W. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomaterialia, 2019, 85: 1–26
CrossRef Google scholar
[9]
Newton J M, Sikora A G, Young S. Chapter 41—Materials-Based Cancer Immunotherapies: Principles of Regenerative Medicine. 3rd ed. Boston: Academic Press, 2019, 715–739
[10]
Gause K T, Wheatley A K, Cui J, Yan Y, Kent S J, Caruso F. Immunological principles guiding the rational design of particles for vaccine delivery. ACS Nano, 2017, 11(1): 54–68
CrossRef Google scholar
[11]
Gu L. Tailored silica nanomaterials for immunotherapy. ACS Central Science, 2018, 4(5): 527–529
CrossRef Google scholar
[12]
Giglio V, Varelaaramburu S, Travaglini L, Fiorini F, Seeberger P H, Maggini L, de Cola L. Reshaping silica particles: mesoporous nanodiscs for bimodal delivery and improved cellular uptake. Chemical Engineering Journal, 2018, 340: 148–154
CrossRef Google scholar
[13]
Yang Y, Lu Y, Abbaraju P L, Zhang J, Zhang M, Xiang G, Yu C. Multi-shelled dendritic mesoporous organosilica hollow spheres: roles of composition and architecture in cancer immunotherapy. Angewandte Chemie International Edition, 2017, 56(29): 8446–8450
CrossRef Google scholar
[14]
Abbaraju P L, Meka A K, Song H, Yang Y, Jambhrunkar M, Zhang J, Xu C, Yu M, Yu C. Asymmetric silica nanoparticles with tunable headtail structures enhance hemocompatibility and maturation of immune cells. Journal of the American Chemical Society, 2017, 139(18): 6321–6328
CrossRef Google scholar
[15]
Wang X, Li X, Ito A, Watanabe Y, Sogo Y, Tsuji N M, Ohno T. Stimulation of in vivo antitumor immunity with hollow mesoporous silica nanospheres. Angewandte Chemie International Edition, 2016, 55(5): 1899–1903
CrossRef Google scholar
[16]
Li X, Wang X, Sogo Y, Ohno T, Onuma K, Ito A. Mesoporous silicacalcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy. Advanced Healthcare Materials, 2013, 2(6): 863–871
CrossRef Google scholar
[17]
Li W A, Lu B Y, Gu L, Choi Y, Kim J, Mooney D J. The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration. Biomaterials, 2016, 83: 249–256
CrossRef Google scholar
[18]
Wang X, Li X, Yoshiyuki K, Watanabe Y, Sogo Y, Ohno T, Tsuji N M, Ito A. Comprehensive mechanism analysis of mesoporous-silica-nanoparticle-induced cancer immunotherapy. Advanced Healthcare Materials, 2016, 5(10): 1169–1176
CrossRef Google scholar
[19]
An M, Li M, Xi J, Liu H. Silica nanoparticle as a lymph node targeting platform for vaccine delivery. ACS Applied Materials & Interfaces, 2017, 9(28): 23466–23475
CrossRef Google scholar
[20]
Cha B G, Jeong J H, Kim J. Extra-large pore mesoporous silica nanoparticles enabling co-delivery of high amounts of protein antigen and toll-like receptor 9 agonist for enhanced cancer vaccine efficacy. ACS Central Science, 2018, 4(4): 484–492
CrossRef Google scholar
[21]
Moon D S, Lee J K. Tunable synthesis of hierarchical mesoporous silica nanoparticles with radial wrinkle structure. Langmuir, 2012, 28(33): 12341–12347
CrossRef Google scholar
[22]
Du X, Qiao S. Dendritic silica particles with center-radial pore channels: promising platforms for catalysis and biomedical applications. Small, 2015, 11(4): 392–413
CrossRef Google scholar
[23]
Shen Z, Li Y, Wen H, Ren X, Liu J, Yang L. Investigation on the role of surfactants in bubble-algae interaction in flotation harvesting of Chlorella vulgaris. Scientific Reports, 2018, 8(1): 3303
CrossRef Google scholar
[24]
Kuai R, Ochyl L J, Bahjat K S, Schwendeman A, Moon J J. Designer vaccine nanodiscs for personalized cancer immunotherapy. Nature Materials, 2016, 16(4): 489–496
CrossRef Google scholar
[25]
Bowen W S, Svrivastava A K, Batra L, Barsoumian H, Shirwan H. Current challenges for cancer vaccine adjuvant development. Expert Review of Vaccines, 2018, 17(3): 207–215
CrossRef Google scholar
[26]
Warrier V U, Makandar A I, Garg M, Sethi G, Kant R, Pal J K, Yuba E, Gupta R K. Engineering anti-cancer nanovaccine based on antigen cross-presentation. Bioscience Reports, 2019, 39(10): BSR20193220
CrossRef Google scholar
[27]
Casaravilla C, Pittini Á, Rückerl D, Seoane P I, Jenkins S J, MacDonald A S, Ferreira A M, Allen J E, Díaz Á. Unconventional maturation of dendritic cells induced by particles from the laminated layer of larval Echinococcus granulosus. Infection and Immunity, 2014, 82(8): 3164–3176
CrossRef Google scholar
[28]
Yoshida S, Gaeta I, Pacitto R, Krienke L, Alge O, Gregorka B, Swanson J A. Differential signaling during macropinocytosis in response to M-CSF and PMA in macrophages. Frontiers in Physiology, 2015, 6: 8
CrossRef Google scholar
[29]
Kasai H, Inoue K, Imamura K, Yuvienco C, Montclare J K, Yamano S. Efficient siRNA delivery and gene silencing using a lipopolypeptide hybrid vector mediated by a caveolae-mediated and temperature-dependent endocytic pathway. Journal of Nanobiotechnology, 2019, 17(1): 11
CrossRef Google scholar
[30]
El-Sayed A, Harashima H. Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Molecular Therapy, 2013, 21(6): 1118–1130
CrossRef Google scholar
[31]
Kubiak Ossowska K, Jachimska B, Al Qaraghuli M, Mulheran P A. Protein interactions with negatively charged inorganic surfaces. Current Opinion in Colloid & Interface Science, 2019, 41: 104–117
CrossRef Google scholar
[32]
Slowing I, Trewyn B G, Lin V S Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. Journal of the American Chemical Society, 2006, 128(46): 14792–14793
CrossRef Google scholar
[33]
Latz E, Schoenemeyer A, Visintin A, Fitzgerald K A, Monks B G, Knetter C F, Lien E, Nilsen N J, Espevik T, Golenbock D T. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nature Immunology, 2004, 5(2): 190–198
CrossRef Google scholar
[34]
Hjortø G M, Larsen O, Steen A, Daugvilaite V, Berg C, Fares S, Hansen M, Ali S, Rosenkilde M M. Differential CCR7 targeting in dendritic cells by three naturally occurring CC-chemokines. Frontiers in Immunology, 2016, 7: 568
CrossRef Google scholar
[35]
Gerlach C, Moseman E A, Loughhead S M, Alvarez D, Zwijnenburg A J, Waanders L, Garg R, de la Torre J C, von Andrian U H. The chemokine receptor CX3CR1 defines three antigen-experienced CD8+ T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity, 2016, 45(6): 1270–1284
CrossRef Google scholar
[36]
Lutz M B, Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity? Trends in Immunology, 2002, 23(9): 445–449
CrossRef Google scholar
[37]
Tugues S, Burkhard S H, Ohs I, Vrohlings M, Nussbaum K, Vom Berg J, Kulig P, Becher B. New insights into IL-12-mediated tumor suppression. Cell Death and Differentiation, 2015, 22(2): 237–246
CrossRef Google scholar
[38]
Kaplanski G, Marin V, Montero Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends in Immunology, 2003, 24(1): 25–29
CrossRef Google scholar
[39]
Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt D P, Pabst R, Lutz M B, Sorokin L. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity, 2005, 22(1): 19–29
CrossRef Google scholar
[40]
Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annual Review of Immunology, 2004, 22(1): 745–763
CrossRef Google scholar
[41]
Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch J V. FcgRIV: a novel FcR with distinct IgG subclass specificity. Immunity, 2005, 23(1): 41–51
CrossRef Google scholar

Acknowledgements

The authors thank for the National Natural Science Foundation of China (Grant No. 81972899), Natural Science Foundation of Tianjin City (Grant No. 18JCQNJC14500), CAMS Innovation Fund for Medical Sciences (Grant No. 2017-I2M-3-022), Specific Program for High-Tech Leader&Team of Tianjin Government, Tianjin innovation and promotion plan key innovation team of immunoreactive biomaterials. The authors declare that they have no conflict of interest.

Electronic Supplementary Material

Supplementary material is available in the online version of this article at http://dx.doi.org/10.1007/s11705-020-2034-6 and is accessible for authorized users.

RIGHTS & PERMISSIONS

2021 Higher Education Press
AI Summary AI Mindmap
PDF(5369 KB)

Accesses

Citations

Detail

Sections
Recommended

/